{"ModuleTitle": "Company Description", "CompanyName": "Evoke Pharma, Inc.", "Symbol": "EVOK", "Address": "420 STEVENS AVENUE SUITE 370, SOLANA BEACH, California, 92075, United States of America", "Phone": "858-345-1494", "Industry": "Major Pharmaceuticals", "Sector": "Health Care", "Region": "North America", "CompanyDescription": "We are a specialty pharmaceutical company focused primarily on the development\r\nof drugs to treat gastrointestinal, or GI, disorders and diseases. We are\r\ndeveloping Gimoti, an investigational metoclopramide nasal spray for the relief\r\nof symptoms associated with acute and recurrent diabetic gastroparesis in\r\nwomen. Diabetic gastroparesis is a GI disorder afflicting millions of\r\nindividuals worldwide and is characterized by slow or delayed gastric emptying\r\nand evidence of gastric retention in the absence of mechanical obstruction and\r\ncan cause various serious digestive system symptoms and other\r\ncomplications. Metoclopramide tablets and injection are the only products\r\ncurrently approved in the United States to treat the symptoms associated with\r\nacute and recurrent diabetic gastroparesis. Gimoti is a novel nasal spray\r\nformulation of metoclopramide designed to provide systemic delivery of the\r\nmolecule through the nasal mucosa.&nbsp;&nbsp;... <a href=\"http://secfilings.nasdaq.com/edgar_conv_html%2f2020%2f03%2f12%2f0001564590-20-010254.html#FIS_BUSINESS\" target=\"_blank\">More</a> ...&nbsp;&nbsp;\r\n", "KeyExecutives": [{"name": "David A. Gonyer", "title": "President, Chief Executive Officer & Director"}, {"name": "Marilyn R. Carlson", "title": "Chief Medical Officer"}, {"name": "Matthew J. D'Onofrio", "title": "Secretary, Treasurer, Chief Business Officer & EVP"}], "Number_of_employees": ["NO INFO"], "Subsidiaries": ["NO INFO"]}